Catherine M. Szyman, CVP, Critical Care at Edwards Lifesciences Corp (EW), sold 5,252 shares at $90.52 ($475K) on 2023-07-10, disclosed to the SEC on 2023-07-10.
Scheduled sale ($475k) by CVP, Critical Care under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $90.46 | 252 | $23K | 4.8% |
| 2 | $90.52 | 5,000 | $453K | 95.2% |
| Total | $90.52 avg | 5,252 | $475K | 100% |
| Filing → |
| EW | SELL | 2023-09-08 | $380K | — | Filing → |
| EW | SELL | 2023-08-09 | $393K | — | Filing → |
| EW | SELL | 2023-06-13 | $429K | — | Filing → |